TE_43
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1MC5_3end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | CEP104 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.14 |
| Counts of samples | TCGA_tumor:268; TCGA_normal:9; GTEx:255 |
| TSS | chr1(-):3822078 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_43.1 | CEP104 | Chimeric | Non-coding | Non-coding | chr1(-):3815497,3815517,3816280,3816370,3821932,3822079 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
